Gene · 8542
Papers3,519
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,519
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Beyond Genotype: Multidomain Biomarker-Integrated Risk Scores Reveal Prognostic phenotypes Among Individuals with High-Risk APOL1 Genotypes. | medRxiv | 2026 | 42282209 | PubTator, text mining | PubMed |
| Quantifying donor-recipient mismatches using recipient-derived sources of donor DNA. | medRxiv | 2026 | 42282199 | PubTator, text mining | PubMed |
| Apolipoprotein L1 genetic testing, family history of hypertension, and kidney disease in a Midwestern U.S. cohort. | Front Nephrol | 2026 | 42266382 | PubTator, text mining | PubMed |
| Update on APOL1 and chronic kidney diseases in children. | Pediatr Nephrol | 2026 | 42249201 | PubTator, text mining | PubMed |
| Apolipoprotein variations across APOE genotypes in young and elderly patients with coronary heart disease. | Biosci Rep | 2026 | 42206501 | PubTator, text mining | PubMed |
| Recurrent Neuro-Renal Syndrome With Acute Kidney Injury From Anti-Pan-Neurofascin Antibody Resurgence: A Case Report. | Kidney Med | 2026 | 42206208 | PubTator, text mining | PubMed |
| APOL1 risk genotypes influence DNA methylation across multiple genomic elements in APOL1-APOL4- MYH9 region in African Americans. | Clin Epigenetics | 2026 | 42163362 | PubTator, text mining | PubMed |
| Reappraisal of Goal-Directed Medical Therapy in Diabetic Kidney Disease: Beyond the Quadruple Therapy Paradigm. | G Ital Nefrol | 2026 | 42143746 | PubTator, text mining | PubMed |
| Case report of a child with kidney disease: consideration of the risk of a single APOL1 G2 allele with a protective N264K variant on the G0 parental chromosome. | BMC Nephrol | 2026 | 42082919 | PubTator, text mining | PubMed |
| Early kidney risk prediction in APOL1 high-risk genotype carriers. | Nat Med | 2026 | 42067710 | PubTator, text mining | PubMed |
| Serum phosphoproteome alterations associated with cardiac troponin I levels in acute myocardial infarction. | Turk J Med Sci | 2026 | 42058992 | PubTator, text mining | PubMed |
| Apolipoprotein L1 (APOL1) and Nephropathy. | G Ital Nefrol | 2026 | 42037283 | PubTator, text mining | PubMed |
| Clinical Utility of Standardized Genetic Testing in Kidney Transplant Candidate Evaluation. | Transplant Direct | 2026 | 42017070 | PubTator, text mining | PubMed |
| Modeling podocytopathies with kidney organoids. | Nephrol Dial Transplant | 2026 | 42012468 | PubTator, text mining | PubMed |
| Apolipoprotein L1 Genetic Testing and Counseling Does Not Reduce Living Kidney Donors' Willingness to Donate : A Hybrid Type 2 Nonrandomized Controlled Trial. | Clin J Am Soc Nephrol | 2026 | 42008800 | PubTator, text mining | PubMed |
| Proteomic risk score for early prediction of kidney disease progression in individuals with APOL1 high-risk genotypes. | Nat Med | 2026 | 41986737 | PubTator, text mining | PubMed |
| Identifying ICAM-1 as a Therapeutic Target for Cytokine Storm in Human Macrophages Through Integrative Bioinformatics Approaches. | Molecules | 2026 | 41976154 | PubTator, text mining | PubMed |
| PLAX-Only M-Mode Scoring System for Risk Stratification of Moderate-to-Severe Left Ventricular Diastolic Dysfunction: A Retrospective Diagnostic Study. | Echocardiography | 2026 | 41940441 | PubTator, text mining | PubMed |
| Recurrence of focal segmental glomerulosclerosis: An updated review of pathophysiology, biomarkers, and therapeutic strategies. | Cell Transplant | 2026 | 41906863 | PubTator, text mining | PubMed |
| Molecular Mechanisms of APOL1-Associated Kidney Disease. | Int J Mol Sci | 2026 | 41898722 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8542/papers?page=3